Curcumin Attenuates Lipopolysaccharide-induced Renal Inflammation
Overview
Affiliations
Renal inflammation is the main pathological change in many acute and chronic kidney diseases. Curcumin, a yellow pigment present in the rhizome of turmeric (Curcuma longa L. Zingiberaceae), was found to be a potential anti-inflammatory agent. The present study aimed to investigate the effects of curcumin on the inflammation of mice kidney and cultured renal tubular epithelial cells (HK-2 cells) induced by lipopolysaccharide (LPS) and to explore the mechanism. Curcumin was injected intraperitoneally before LPS administration. Renal inflammation was assessed by evaluating monocyte chemoattractant protein-1 (MCP-1) expression and macrophage infiltration in renal tissue using immunohistochemical methods, and also by measuring renal MCP-1 mRNA level using Real-Time polymerase chain reaction (PCR). HK-2 cells were cultured to investigate the in vitro effect of curcumin against LPS-induced renal inflammation. The expression of MCP-1 and interleukin-8 (IL-8) mRNA was measured by Real-Time PCR. The expression of MCP-1 and IL-8 protein in supernatant was detected by enzyme-linked immunosorbent assay (ELISA). The activity of nuclear factor (NF)-κB was detected by electrophoretic mobility shift assay (EMSA). The results demonstrated that curcumin could inhibit LPS-induced renal MCP-1 mRNA expression. Curcumin also significantly inhibited the expression of MCP-1 and IL-2 mRNA in HK-2 cells, and partially inhibited the secretion of MCP-1 and IL-8. Furthermore, curcumin was found to inhibit the DNA-binding activity of NF-κB. The present study demonstrated that curcumin has a protective effect on LPS-induced experimental renal inflammation, and this effect might be attributed to its inhibitory effects on MCP-1 mRNA expression and DNA-binding activity of NF-κB. Hence, curcumin might be potentially useful in some kidney diseases by preventing renal inflammation.
Casanova F, Pereira C, Ribeiro A, Castro P, Freixo R, Martins E Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139863 PMC: 10747507. DOI: 10.3390/ph16121737.
Sulforaphane Reduces the Chronic Inflammatory Immune Response of Human Dendritic Cells.
Fernandez-Prades L, Brasal-Prieto M, Alba G, Martin V, Montserrat-de la Paz S, Cejudo-Guillen M Nutrients. 2023; 15(15).
PMID: 37571342 PMC: 10421388. DOI: 10.3390/nu15153405.
Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Sadeghi M, Dehnavi S, Asadirad A, Xu S, Majeed M, Jamialahmadi T Inflammopharmacology. 2023; 31(3):1069-1093.
PMID: 36997729 PMC: 10062691. DOI: 10.1007/s10787-023-01136-w.
Curcumin enhances p-cresyl sulfate-induced cytotoxic effects on renal tubular cells.
Wei C, Wu T, Wu S, Chen Y, Pan Y, Chien Y Int J Med Sci. 2022; 19(7):1138-1146.
PMID: 35919818 PMC: 9339410. DOI: 10.7150/ijms.72646.
Promoting Plant-Based Therapies for Chronic Kidney Disease.
Khan M, Kassianos A, Hoy W, Alam A, Healy H, Gobe G J Evid Based Integr Med. 2022; 27:2515690X221079688.
PMID: 35243916 PMC: 8902019. DOI: 10.1177/2515690X221079688.